We extracted a granule-rich sediment from normal human neutrophils and subjected it to chromatographic, electrophoretic, and functional analysis. The extract contained three small (molecular weight less than 3,500) antibiotic peptides that were named human neutrophil peptide (HNP)-1, HNP-2, and HNP-3, and which will be referred to as "defensins." HNP 1-3, a mixture of the three defensins, killed Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli effectively in vitro when tested in 10 mM phosphate buffer containing certain nutrients, but it had little or no bactericidal activity in nutrient-free buffer. In contrast, the nutrient-free buffer supported a high degree of activity by HNP 1-3 against Cryptococcus neoformans. In addition to its antibacterial and antifungal properties, HNP 1-3 directly inactivated herpes simplex virus, Type 1. Two of the individual purified defensins, HNP-1 and HNP-2, were as microbicidal as the mixture HNP 1-3. HNP-3 was less active than the other defensins against most but not all of the microbes tested. Immunoperoxidase stains revealed HNP 1-3 to have a granular localization in the neutrophil's cytoplasm by light microscopy. Frozen thin section immunogold transmission electron microscopy showed HNP 1-3 to be localized in azurophil granules. These studies define a broad-spectrum antimicrobial system in human neutrophils. The defensin system may operate in conjunction with or independently from oxygen-dependent microbicidal processes to enable human neutrophils to inactivate and destroy potential pathogens.
T Ganz, M E Selsted, D Szklarek, S S Harwig, K Daher, D F Bainton, R I Lehrer
Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1981 | 1979 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 4 | 14 | 20 | 21 | 33 | 26 | 29 | 30 | 26 | 38 | 36 | 38 | 29 | 26 | 34 | 40 | 34 | 43 | 40 | 29 | 38 | 37 | 35 | 27 | 24 | 23 | 36 | 16 | 17 | 16 | 15 | 16 | 18 | 26 | 32 | 32 | 32 | 28 | 10 | 7 | 1 | 1 | 1077 |
Title and authors | Publication | Year |
---|---|---|
Alpha-defensin increase in peripheral blood mononuclear cells from patients with hepatitis C virus chronic infection
A Aceti, ML Mangoni, C Pasquazzi, D Fiocco, M Marangi, R Miele, B Zechini, M Borro, I Versace, M Simmaco |
Journal of Viral Hepatitis | 2006 |
Antimicrobial Peptides and Human Disease
WM Shafer |
2006 | |
The changing of the guard: Molecular diversity and rapid evolution of β-defensins
CA Semple, P Gautier, K Taylor, JR Dorin |
Molecular Diversity | 2006 |
CC Chemokines Induce Neutrophils to Chemotaxis, Degranulation, and ??-Defensin Release
MS Jan, YH Huang, B Shieh, RH Teng, YP Yan, YT Lee, KK Liao, C Li |
JAIDS Journal of Acquired Immune Deficiency Syndromes | 2006 |
Defensins in innate antiviral immunity
ME Klotman, TL Chang |
Nature Reviews Immunology | 2006 |
Crystal structures of human alpha-defensins HNP4, HD5, and HD6
A Szyk, Z Wu, K Tucker, D Yang, W Lu, J Lubkowski |
Protein science : a publication of the Protein Society | 2006 |
Contribution of alpha- and beta-defensins to lung function decline and infection in smokers: an association study
AM Wallace, JQ He, KM Burkett, J Ruan, JE Connett, NR Anthonisen, PD Paré, AJ Sandford |
Respiratory Research | 2006 |
The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota
VL Moal, AL Servin |
Clinical microbiology reviews | 2006 |
Expression of β Defensins in Ocular Surface Tissue of Experimentally Developed Allergic Conjunctivitis Mouse Model
A Ikeda, Y Nakanishi, T Sakimoto, J Shoji, M Sawa, N Nemoto |
Japanese Journal of Ophthalmology | 2006 |
Aurelin, a novel antimicrobial peptide from jellyfish Aurelia aurita with structural features of defensins and channel-blocking toxins
TV Ovchinnikova, SV Balandin, GM Aleshina, AA Tagaev, YF Leonova, ED Krasnodembsky, AV Men’shenin, VN Kokryakov |
Biochemical and Biophysical Research Communications | 2006 |
Antimicrobial Activity of Inducible Human β Defensin-2 Against Mycoplasma pneumoniae
K Kuwano, N Tanaka, T Shimizu, Y Kida |
Current Microbiology | 2006 |
A mitogenic defensin from white cloud beans (Phaseolus vulgaris)
JH Wong, XQ Zhang, HX Wang, TB Ng |
Peptides | 2006 |
Recent advances in the research and development of human defensins
H Chen, Z Xu, L Peng, X Fang, X Yin, N Xu, P Cen |
Peptides | 2006 |
Expression Pattern of Human Neutrophil Peptides (HNP 1-3) in Chronic Hyperplastic Candidiasis
AA Sewvandini, I Morio, M Sunakawa, K Nagumo, N Okada |
Oral Medicine & Pathology | 2006 |
The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes
K Thedieck, T Hain, W Mohamed, BJ Tindall, M Nimtz, T Chakraborty, J Wehland, L Jänsch |
Molecular Microbiology | 2006 |
Advances in antimicrobial peptide immunobiology
NY Yount, AS Bayer, YQ Xiong, MR Yeaman |
Biopolymers | 2006 |
Defensin: a multifunctional molecule lives up to its versatile name
C Kim, SH Kaufmann |
Trends in Microbiology | 2006 |
Expression and purification of Artogeia rapae lysozyme II cDNA in a baculovirus/insect cell system
IS BANG, SM YOE, CS KANG |
Entomological Research | 2006 |
Associations between Defensin Polymorphism and Somatic Cell Count in Milk and Milk Utility Traits in Jersey Dairy Cows
K Wojdak-Maksymiec, M Kmieć, A ŻUkiewicz |
Journal of Veterinary Medicine Series A | 2006 |
Defensins as anti-infective and immunomodulatory agents
K Adermann |
Expert Opinion on Therapeutic Patents | 2006 |
A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts
S Nuding, K Fellermann, J Wehkamp, HA Mueller, EF Stange |
Journal of Microbiological Methods | 2006 |
Paneth cell antimicrobial peptides: Topographical distribution and quantification in human gastrointestinal tissues
J Wehkamp, H Chu, B Shen, RW Feathers, RJ Kays, SK Lee, CL Bevins |
FEBS Letters | 2006 |
Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium
WS Jang, HK Kim, KY Lee, SA Kim, YS Han, IH Lee |
FEBS Letters | 2006 |
Expression and purification of recombinant human α-defensins in Escherichia coli
M Pazgier, J Lubkowski |
Protein Expression and Purification | 2006 |
Structural and Functional Characterization of the Conserved Salt Bridge in Mammalian Paneth Cell α-Defensins: SOLUTION STRUCTURES OF MOUSE CRYPTDIN-4 AND (E15D)-CRYPTDIN-4
KJ Rosengren, NL Daly, LM Fornander, LM Jönsson, Y Shirafuji, X Qu, HJ Vogel, AJ Ouellette, DJ Craik |
The Journal of biological chemistry | 2006 |
Oral Antimicrobial Peptides and Biological Control of Caries
BA Dale, R Tao, JR Kimball, RJ Jurevic |
BMC oral health | 2006 |
Macrophages Acquire Neutrophil Granules for Antimicrobial Activity against Intracellular Pathogens
BH Tan, C Meinken, M Bastian, H Bruns, A Legaspi, MT Ochoa, SR Krutzik, BR Bloom, T Ganz, RL Modlin, S Stenger |
Journal of immunology (Baltimore, Md. : 1950) | 2006 |
Immune Response and Immunotherapy to Cryptococcus Infections
Q Zhou, WJ Murphy |
Immunologic Research | 2006 |
Antimicrobial activity of inducible human beta defensin-2 against Mycoplasma pneumoniae.
Kuwano K, Tanaka N, Shimizu T, Kida Y |
Current Microbiology | 2006 |